In 466 patients with coronary disease undergoing TAVI, deferring PCI was non-inferior to PCI before TAVI for 1-year death, MI, stroke or major bleeding (24% vs 26%; HR 0.89; p=0.0008 for non-inferiority).
RCTn = 466
Delewi et al. Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial